Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis

医学 氯胺酮 荟萃分析 耐受性 相对风险 重性抑郁障碍 随机对照试验 交叉研究 萧条(经济学) 临床试验 内科学 置信区间 不利影响 麻醉 安慰剂 替代医学 经济 病理 扁桃形结构 宏观经济学
作者
Ying Xu,Maree L. Hackett,Gregory Carter,Colleen Loo,Verònica Gálvez,Nick Glozier,Paul Glue,Kyle Lapidus,Alexander McGirr,Andrew A. Somogyi,Philip B. Mitchell,Anthony Rodgers
出处
期刊:The International Journal of Neuropsychopharmacology [University of Oxford]
卷期号:19 (4): pyv124-pyv124 被引量:205
标识
DOI:10.1093/ijnp/pyv124
摘要

Several recent trials indicate low-dose ketamine produces rapid antidepressant effects. However, uncertainty remains in several areas: dose response, consistency across patient groups, effects on suicidality, and possible biases arising from crossover trials. A systematic search was conducted for relevant randomized trials in Medline, Embase, and PsycINFO databases up to August 2014. The primary endpoints were change in depression scale scores at days 1, 3 and 7, remission, response, suicidality, safety, and tolerability. Data were independently abstracted by 2 reviewers. Where possible, unpublished data were obtained on treatment effects in the first period of crossover trials. Nine trials were identified, including 201 patients (52% female, mean age 46 years). Six trials assessed low-dose ketamine (0.5mg/kg i.v.) and 3 tested very low-dose ketamine (one trial assessed 50mg intra-nasal spray, another assessed 0.1–0.4mg/kg i.v., and another assessed 0.1–0.5mg/kg i.v., intramuscular, or s.c.). At day 3, the reduction in depression severity score was less marked in the very low-dose trials (P homogeneity <.05) and among bipolar patients. In analyses excluding the second period of crossover trials, response rates at day 7 were increased with ketamine (relative risk 3.4, 95% CI 1.6–7.1, P=.001), as were remission rates (relative risk 2.6, CI 1.2–5.7, P=.02). The absolute benefits were large, with day 7 remission rates of 24% vs 6% (P=.02). Seven trials provided unpublished data on suicidality item scores, which were reduced on days 1 and 3 (both P<.01) but not day 7. Low-dose ketamine appears more effective than very low dose. There is substantial heterogeneity in clinical response, with remission among one-fifth of patients at 1 week but most others having benefits that are less durable. Larger, longer term parallel group trials are needed to determine if efficacy can be extended and to further assess safety.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zokor完成签到 ,获得积分0
3秒前
努力退休小博士完成签到 ,获得积分10
4秒前
橙子完成签到,获得积分10
5秒前
陈补天完成签到 ,获得积分10
6秒前
CipherSage应助慧灰huihui采纳,获得10
7秒前
乐观健柏完成签到,获得积分10
8秒前
10秒前
CodeCraft应助大橙子采纳,获得10
10秒前
量子星尘发布了新的文献求助10
11秒前
jeeya完成签到,获得积分10
12秒前
14秒前
科目三应助科研通管家采纳,获得10
14秒前
科目三应助科研通管家采纳,获得10
14秒前
伦语发布了新的文献求助10
14秒前
顾矜应助科研通管家采纳,获得10
14秒前
xuzj应助科研通管家采纳,获得10
14秒前
xuzj应助科研通管家采纳,获得10
14秒前
14秒前
NexusExplorer应助科研通管家采纳,获得10
14秒前
14秒前
14秒前
丘比特应助科研通管家采纳,获得10
15秒前
yull完成签到,获得积分10
15秒前
小巧书雪完成签到,获得积分10
18秒前
大大怪将军完成签到,获得积分10
19秒前
哈哈哈完成签到 ,获得积分0
19秒前
小怪完成签到,获得积分10
20秒前
爱吃泡芙完成签到,获得积分10
21秒前
白桃战士完成签到,获得积分10
22秒前
24秒前
qingchenwuhou完成签到 ,获得积分10
24秒前
XXX完成签到,获得积分10
25秒前
锡嘻完成签到 ,获得积分10
25秒前
26秒前
彗星入梦完成签到 ,获得积分10
26秒前
恋恋青葡萄完成签到,获得积分10
26秒前
隐形万言完成签到,获得积分10
28秒前
Time完成签到,获得积分10
28秒前
土木研学僧完成签到,获得积分10
29秒前
yjy完成签到 ,获得积分10
29秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038201
求助须知:如何正确求助?哪些是违规求助? 3575940
关于积分的说明 11373987
捐赠科研通 3305747
什么是DOI,文献DOI怎么找? 1819274
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022